IL6 and obesity disorder: The mechanistic pathway implicated in obesity‐related hypercoagulability includes the actions of adipocytokines, coagulation factors hyperactivity and increased inflammation (tumour necrosis factor [TNF], interleukin‐6 [IL‐6]) among others.43